Home Government Fed agency turns to Regeneron for first drugs against MERS

Fed agency turns to Regeneron for first drugs against MERS

SHARE

Regeneron lab scientists have identified two antibodies to potentially prevent and treat highly fatal Middle East Respiratory Syndrome.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email